Veon pays $47m mix of cash and Kyivstar shares for 33.8% of Jungo TV

Veon has agreed to pay $5 million in cash plus roughly $42.3 million in Kyivstar shares for a stake of almost 33.8% in US-based streaming company Jungo TV — a deal that will not close until 2027 at the earliest, pending regulatory approvals.

The total consideration works out at just over $47 million. Nearly nine-tenths of it is being paid in paper rather than cash: Veon is handing over 2.35 million existing shares in Kyivstar, its Ukrainian operation, at a stated value of $18 per share — an implied Kyivstar equity valuation of roughly $1.4 per share-issuing unit that also gives observers a rare, explicit per-share price for the Ukrainian operator.

What does Veon actually get?

The headline asset is content. Veon plans to distribute Jungo TV programming across five of its markets: Pakistan, Bangladesh, Uzbekistan, Kazakhstan and Ukraine. Those are precisely the emerging-market footprints where the Amsterdam-headquartered group has been pushing its so-called digital operator strategy — the pivot from connectivity revenues toward services sold on top of the network.

Jungo TV's most prominent offering is the All Women's Sports Network (AWSN), a service co-founded by actress Whoopi Goldberg and dedicated to female sport. Its channels are streamed in 65 countries through various platforms and partners in each market. That existing distribution matters to Veon's case: the operator is not just buying content it must build an audience for, but one that already reaches viewers internationally.

What is the commercial logic?

Veon frames the deal as a strengthening of its digital entertainment business. The company expects access to fresh content to lift customer engagement and revenue through three channels it names explicitly:

• increased subscriptions
• sponsorship
• content licensing

CEO Kaan Terzioglu was direct about the strategic framing. Entertainment is "central to our digital operator strategy: bringing customers services they value throughout the day," he said.

"Jungo TV, and particularly AWSN, bring together distinctive content, an exciting women's sports platform and established international distribution," Terzioglu added. "By combining these strengths with our digital platforms and customer relationships, we aim to bring compelling entertainment to more people, deepen engagement and build new sources of digital revenue."

What the announcement does not say

For a transaction pitched as an engagement and revenue driver, the statement is thin on baselines. Veon offers no subscriber targets, no projected revenue uplift, no ARPU expectations and no timeline for when the content will go live in each of the five markets. The engagement and monetisation gains the deal is supposed to deliver remain, for now, assertions rather than modelled outcomes.

The payment structure also warrants attention. By settling most of the price in Kyivstar shares rather than cash, Veon conserves liquidity — a consistent priority for a group with heavy emerging-market exposure — while effectively using its Ukrainian asset as acquisition currency. Whether Kyivstar minority-direction economics at $18 per share hold through 2027 is a question the deal's long completion window leaves open.

The 2027 completion date itself is unusually distant for a stake of this size, and Veon attributes it only to "the usual closing conditions" including regulatory approvals. That phrasing covers a wide range of outcomes across the multiple jurisdictions involved.

Why it fits the wider pattern

The purchase aligns with Veon's previously stated insistence that digital services are the telco future — a position Terzioglu has argued publicly — and follows the group's broader effort to monetise customer relationships beyond voice and data. Content distribution across Pakistan, Bangladesh, Uzbekistan, Kazakhstan and Ukraine gives the strategy a concrete, if modest, test case.

Whether the $47 million bet converts into measurable subscription and licensing revenue will become clear only after regulatory sign-offs and the 2027 close.